Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Yoram Menachem"'
Autor:
Liat Deutsch, Inbal Houri, Ziv Ben-Ari, Amir Shlomai, Ella Veitsman, Oranit Cohen-Ezra, Assaf Issachar, Orna Mor, Yael Gozlan, Rafael Bruck, Yoram Menachem, Shira Zelber-Sagi, Helena Katchman, Oren Shibolet
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Hepatitis C virus (HCV) infection is a leading cause of chronic liver disease and hepatocellular carcinoma. Treatment with first generation protease inhibitors (PI) + peg-interferon (pegIFN) and ribavirin (RBV) achieved sustained
Externí odkaz:
https://doaj.org/article/8d8a09a64891489ca8134d6425a34e9c
Autor:
Helena Katchman, Assaf Issachar, Orna Mor, Oren Shibolet, Yoram Menachem, Ella Veitsman, Amir Shlomai, Liat Deutsch, Oranit Cohen-Ezra, Rafael Bruck, Yael Gozlan, Shira Zelber-Sagi, Ziv Ben-Ari, Inbal Houri
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Infectious Diseases
BMC Infectious Diseases
Background Hepatitis C virus (HCV) infection is a leading cause of chronic liver disease and hepatocellular carcinoma. Treatment with first generation protease inhibitors (PI) + peg-interferon (pegIFN) and ribavirin (RBV) achieved sustained virologic
Publikováno v:
Archives of Clinical and Medical Case Reports.
Autor:
Hedva Lerman, Yoram Menachem, Dov Hershkovitz, Yaniv Zohar, Eyal Mishani, Oren Shibolet, Mikhail Kesler, Einat Even-Sapir, Charles D. Levine
Publikováno v:
Journal of Nuclear Medicine. 60:185-191
Background:68Ga-Prostate Specific Membrane Antigen (68Ga-PSMA), a positron emission tomography (PET) tracer that was recently introduce for imaging of prostate cancer, may accumulate in other solid tumors including Hepatocellular Carcinoma (HCC). The
Autor:
Yoram Menachem, Tarek Saadi, Oren Shibolet, Rawi Hazzan, Assy Nimer, Ehud Zigmond, Yana Davidov, Michal Cohen-Naftaly, Amir Shlomai, Avia Rakovsky, Eli Zuckerman, Rifaat Safadi, Yoav Lurie, Yael Gozlan, Ella Mendelson, Eitan Galun, Helena Katchman, Rachel Shirazi, Ziv Ben-Ari, Orna Mor, Yaakov Maor, Abu Moch Saif, Efrat Bucris, Marius Braun, Ohad Etzion, Ella Veizman
Publikováno v:
Antiviral therapy. 24(3)
Background Direct-acting antiviral (DAA) therapy has dramatically increased sustained virological response rates in HCV-infected patients. However, resistance-associated substitutions (RAS) interfering with NS3- and NS5A-targeted therapy, still emerg
Autor:
Yoram Menachem, Ido Nachmany, Richard Nakache, Ido Wolf, Ravit Geva, Nir Lubezky, Helena Katchman, Guy Lahat, Joseph M. Klausner, Yaacov Goykhman, Oren Shibolet, Guy Meyerovich
Publikováno v:
Transplantation proceedings. 51(6)
Background Liver transplantation (LT) and liver resection (LR) are curative treatment options for patients with hepatocellular carcinoma within the Milan criteria. Severe organ shortage dictates the preference for LR. Our aim was to provide an intent
Surgical Treatment of Hepatocellular Carcinoma with a Tumor Thrombus Extending into the Right Atrium
Autor:
Nir, Lubezky, Ido, Nachmany, Yaacov, Goykhman, Yanai, Ben-Gal, Yoram, Menachem, Ravit, Geva, Joseph M, Klausner, Richard, Nakache
Publikováno v:
The Israel Medical Association journal : IMAJ. 20(9)
Autor:
Matthias Carlebach, Ruthy Hadary, Oren Shibolet, Oranit Cohen-Ezra, Yoram Menachem, Orly Sne Arbib, Michal Cohen-Naftaly, Yulia Kovalev, Ella Veitsman, Ran Tur-Kaspa, Tova Goldberg, Haim Shirin, Rawi Hazzan, Helena Katchman, Ran Oren, Michal Carmiel, Eli Zuckerman, Yaffa Ashur, Rifaat Safadi, Marius Braun, Tarek Saadi, Amir Shlomai, Eyal Ashkenazi, Yona Kitay, Saif Abu-Mouch, Rafael Bruk
Publikováno v:
Journal of Hepatology. 70:e251-e252
Autor:
Yoram Menachem, Yaron Ilan, Olga Kolker, Oren Shibolet, Ruslana Alper, Shivti Trop, Arnon Nagler
Publikováno v:
Microbes and Infection. 7:825-835
T lymphocytes expressing NK1.1 marker (NKT) have been suggested to play crucial roles in immune modulation. Aim.– To determine the role of NK1.1+ cells in induction and maintenance of pro-inflammatory and/or tolerizing responses. Methods.– Coliti
Autor:
Alexandra Lavy, Alon Lang, Simon Bar-Meir, Herma Fidder, Yoram Menachem, Eytan Bardan, Benjamin Avidan, Yehuda Chowers
Publikováno v:
Digestion. 72:124-128
Background: Relapse after an initial response to infliximab therapy poses a problem for maintenance treatment. Aim: To assess the effects of increasing the infliximab dosage in Crohn’s disease (CD) patients who initially responded but flared during